BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32777395)

  • 41. IgG4-related cranio-spinal hypertrophic pachymeningitis involving the internal auditory canal.
    Yangue Y; Gambaracci G; Floridi P; Fiacca A; Guerriero A; Giansanti M; Scialpi M
    J Biol Regul Homeost Agents; 2016; 30(3):915-919. PubMed ID: 27655521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoglobulin G4-related disease involving both cerebral parenchyma and spinal cord: A case report.
    Lin J; Zheng L; Zhou D; Hong Z
    J Neuroimmunol; 2019 Oct; 335():577018. PubMed ID: 31401417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.
    De Virgilio A; de Vincentiis M; Inghilleri M; Fabrini G; Conte M; Gallo A; Rizzo MI; Greco A
    Immunol Res; 2017 Feb; 65(1):386-394. PubMed ID: 27592235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.
    Xia C; Li P
    Front Neurol; 2022; 13():986694. PubMed ID: 36188377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration.
    Tanboon J; Felicella MM; Bilbao J; Mainprize T; Perry A
    Clin Neuropathol; 2013; 32(4):291-7. PubMed ID: 23320997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease.
    Chan SK; Cheuk W; Chan KT; Chan JK
    Am J Surg Pathol; 2009 Aug; 33(8):1249-52. PubMed ID: 19561447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracranial Multiple Pseudotumor Due to Immunoglobulin G4-Related Disease without Other Lesions: Case Report and Literature Review.
    Kuroda N; Inenaga C; Arai Y; Otsuki Y; Tanaka T
    World Neurosurg; 2019 Dec; 132():69-74. PubMed ID: 31470167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurological involvement of IgG4-related disease: description of a case and review of the literature.
    Varrassi M; Gianneramo C; Arrigoni F; Cerrone P; Sucapane P; Marini C; Splendiani A
    Neuroradiol J; 2018 Apr; 31(2):196-202. PubMed ID: 28423973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoglobulin G4-Related Disease Masquerading an Epidural Spinal Cord Tumor.
    Abdulla E; Luther H; Shah T; Chandran N
    J Neurosci Rural Pract; 2021 Apr; 12(2):424-426. PubMed ID: 33927535
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case.
    Elmaci I; Altinoz MA; Akdemir G; Sari R; Baskan O; Ozpinar A; Hacker E; Sav A
    Clin Neurol Neurosurg; 2021 Jan; 200():106342. PubMed ID: 33158629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin G4-related epidural inflammatory pseudotumor presenting with pulmonary complications and spinal cord compression: case report.
    Rumalla K; Smith KA; Arnold PM
    J Neurosurg Spine; 2017 Jun; 26(6):688-693. PubMed ID: 28304239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgG4-related intracranial disease.
    Goulam-Houssein S; Grenville JL; Mastrocostas K; Munoz DG; Lin A; Bharatha A; Vlachou PA
    Neuroradiol J; 2019 Feb; 32(1):29-35. PubMed ID: 30320530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
    Lu LX; Della-Torre E; Stone JH; Clark SW
    JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgG4-related intracranial hypertrophic pachymeningitis with skull hyperostosis: a case report.
    Lin CK; Lai DM
    BMC Surg; 2013 Sep; 13():37. PubMed ID: 24053604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypertrophic pachymeningitis and tracheobronchial stenosis in IgG4-related disease: case presentation and literature review.
    Yamashita H; Takahashi Y; Ishiura H; Kano T; Kaneko H; Mimori A
    Intern Med; 2012; 51(8):935-41. PubMed ID: 22504255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis.
    Soares C; Martins DF; Pestana-Silva R; Honavar M; Faria O; Abreu P; Costa A
    J Neuroimmunol; 2019 Sep; 334():576997. PubMed ID: 31254930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A nationwide survey of hypertrophic pachymeningitis in Japan.
    Yonekawa T; Murai H; Utsuki S; Matsushita T; Masaki K; Isobe N; Yamasaki R; Yoshida M; Kusunoki S; Sakata K; Fujii K; Kira J
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):732-9. PubMed ID: 24273222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Overlapping Case of IgG4-Related Disease and Systemic Lupus Erythematosus.
    Naramala S; Biswas S; Adapa S; Gayam V; Konala VM; Bose S
    J Investig Med High Impact Case Rep; 2019; 7():2324709619862297. PubMed ID: 31319713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertrophic spinal pachymeningitis: idiopathic vs. IgG4-related.
    Ezzeldin M; Shawagfeh A; Schnadig V; Smith RG; Fang X
    J Neurol Sci; 2014 Dec; 347(1-2):398-400. PubMed ID: 25454650
    [No Abstract]   [Full Text] [Related]  

  • 60. [IgG4- and MPO-ANCA-associated hypertrophic pachymeningitis].
    Aragonès JM; Arias-Rivero M; García-Barrionuevo JM; Lucchetti G
    Rev Neurol; 2015 Nov; 61(10):454-7. PubMed ID: 26553176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.